Pregled bibliografske jedinice broj: 1194841
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis // Croatian medical journal, 55 (2014), 562-576 doi:10.3325/cmj.2014.55.562 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1194841 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cardiac allograft vasculopathy: diagnosis, therapy,
and prognosis
(Cardiac allograft vasculopathy: diagnosis, therapy,
and prognosis.)
Autori
Skoric, B ; Cikes, M ; Ljubas Macek, J ; Baricević, Z ; Skorak, I ; Gasparovic, H ; Biocina, B ; Milicic, D.
Izvornik
Croatian medical journal (0353-9504) 55
(2014);
562-576
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
cardiac allograft vasculopathy
Sažetak
Development of cardiac allograft vasculopathy represents the major determinant of long-term survival in patients after heart transplantation. Due to graft denervation, these patients seldom present with classic symptoms of angina pectoris, and the first clinical presentations are progressive heart failure or sudden cardiac death. Although coronary angiography remains the routine technique for coronary artery disease detection, it is not sensitive enough for screening purposes. This is especially the case in the first year after transplantation when diffuse and concentric vascular changes can be easily detected only by intravascular ultrasound. The treatment of the established vasculopathy is disappointing, so the primary effort should be directed toward early prevention and diagnosis. Due to diffuse vascular changes, revascularization procedures are restricted only to a relatively small proportion of patients with favorable coronary anatomy. Percutaneous coronary intervention is preferred over surgical revascularization since it leads to better acute results and patient survival. Although there is no proven long-term advantage of drug-eluting stents for the treatment of in-stent restenosis, they are preferred over bare-metal stents. Severe vasculopathy has a poor prognosis and the only definitive treatment is retransplantation. This article reviews the present knowledge on the pathogenesis, diagnosis, treatment, and prognosis of cardiac allograft vasculopathy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Boško Skorić
(autor)
Damir Miličić
(autor)
Bojan Biočina
(autor)
Zrinko Baričević
(autor)
Hrvoje Gašparović
(autor)
Maja Čikeš
(autor)